Bayer AG Logo

Bayer AG

A life science firm providing pharmaceuticals, consumer health, and crop science solutions.

BAY | F

Overview

Corporate Details

ISIN(s):
DE0005752059 (+2 more)
LEI:
549300J4U55H3WP1XT59
Country:
Germany
Address:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bayer AG is a global life science company with core competencies in healthcare and agriculture. Guided by its mission, "Health for all, Hunger for none," the company develops and commercializes products and services designed to address fundamental human needs and global challenges. Its operations are organized into three divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, offering over-the-counter medications and supplements; and Crop Science, providing seeds, crop protection, and digital farming solutions. Bayer's portfolio includes numerous world-famous brands and aims to foster innovation in health and nutrition to support a growing and aging global population.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 12:09
Declaration of Voting Results & Voting Rights Announcements
English 12.6 KB
2025-08-06 00:00
Interim Report
Half-yearly financial report 2025
English 472.4 KB
2025-08-04 13:55
Major Shareholding Notification
English 86.6 KB
2025-07-31 23:15
Earnings Release
Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings g…
English 12.2 KB
2025-07-24 14:09
Major Shareholding Notification
English 83.7 KB
2025-07-22 11:51
Declaration of Voting Results & Voting Rights Announcements
English 86.3 KB
2025-07-04 07:38
Declaration of Voting Results & Voting Rights Announcements
English 86.4 KB
2025-06-26 15:30
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-25 12:35
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-23 13:01
Declaration of Voting Results & Voting Rights Announcements
English 80.3 KB
2025-06-12 12:54
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-05-22 09:04
Major Shareholding Notification
English 23.4 KB
2025-05-21 14:01
Major Shareholding Notification
English 18.5 KB
2025-05-19 09:00
Declaration of Voting Results & Voting Rights Announcements
English 23.4 KB
2025-05-17 07:59
Declaration of Voting Results & Voting Rights Announcements
English 18.5 KB

Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bayer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bayer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NuCana plc Logo
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
United States of America NCNA
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom NFX
Nurix Therapeutics, Inc. Logo
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America NRIX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX
NutriBand Inc. Logo
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
United States of America NTRB
Nuvalent, Inc. Logo
Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.
United States of America NUVL
Nuvation Bio Inc. Logo
A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.
United States of America NUVB
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan 4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland OBSN
OCULAR THERAPEUTIX, INC Logo
Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.
United States of America OCUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.